438
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Clinical Features of Ocular Toxocariasis in Adult Korean Patients

, , , &
Pages 207-216 | Received 25 Sep 2014, Accepted 01 Dec 2014, Published online: 07 Jan 2015
 

Abstract

Purpose: To investigate the clinical characteristics and treatment results of adult patients with ocular toxocariasis.

Methods: A total of 54 consecutive patients who were clinically and serologically diagnosed with ocular toxocariasis were retrospectively reviewed.

Results: Among patients, 66.7 and 77.3% showed increases in eosinophil cationic protein (ECP) and total Ig E in serum, respectively. Four eyes (7.2%) initially presented as neuroretinitis with subsequent motile retinal lesion. The recurrence rates in the combination treatment group with albendazole and corticosteroids were significantly lower than those in the steroid-alone group during the mean follow-up of 27.6 months (p = 0.001).

Conclusions: The adjunctive test of serum total IgE level may be helpful for the diagnosis of ocular toxocariasis. Ocular toxocariasis should be considered in the differential diagnosis of unilateral neuroretinitis with subsequent motile retinal lesion. Combined treatment with albendazole and corticosteroids appeared to be effective for reducing the recurrence of intraocular inflammation.

Declaration of interest

Won Ki Lee has served on advisory boards for Novartis and Bayer, and has received consultancy fees from these companies. He has received payments for lectures from Novartis, Bayer, and Allergan. The rest of the authors have no financial disclosure to report. There was no sponsor or funding organization involved in the study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.